Medifron DBT Inc.
Records under this name other than the patents Medifron DBT Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 5 of 5 · Back to Medifron DBT Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,580,848 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof Lapsed on the fee record Ended Nov 12, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2017 | From the USPTO record |
| US 8,507,553 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof Lapsed on the fee record Ended Aug 13, 2017 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2017 | From the USPTO record |
| US 8,455,542 | Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof Lapsed on the fee record Ended Jun 4, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 4, 2017 | From the USPTO record |
| US 6,476,076 | Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof Lapsed on the fee record Ended Nov 5, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2014 | From the USPTO record |
| US 6,872,748 | Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same Lapsed on the fee record Ended Mar 29, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2013 | From the USPTO record |